- Home
- HEPS vs VOR Comparison
HEPS vs VOR Comparison
Compare HEPS & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HEPS | VOR |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | Turkey | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HEPS | VOR |
|---|---|---|
| Price | $2.70 | $18.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $3.31 | ★ $39.00 |
| AVG Volume (30 Days) | 380.7K | ★ 1.2M |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.24 | N/A |
| Revenue Next Year | $29.65 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $6.50 |
| 52 Week High | $3.30 | $30.40 |
Technical Indicators
Market Signals| Indicator | HEPS | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 40.25 |
| Support Level | $2.52 | $17.35 |
| Resistance Level | $2.78 | $18.44 |
| Average True Range (ATR) | 0.08 | 1.18 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 79.49 | 29.33 |
Price Performance
Historical ComparisonAbout HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.